Log in or Sign up for Free to view tailored content for your specialty!
Sjögren’s Syndrome News
Patients with pulmonary arterial hypertension with CTD exhibit 59% 10-year survival rate
Patients with pulmonary arterial hypertension associated with connective tissue disease demonstrate a “poor” 10-year rate of 59.9%, according to data published in Rheumatology.
Anti-SSA/RO antibodies predict adverse pregnancy outcomes
The presence of anti-SSA/RO antibodies in pregnant patients can predict adverse pregnancy outcomes, including spontaneous abortion, according to data published in Pediatric Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
New autoantibody analysis may improve early connective tissue disease diagnoses
A novel, fully automated multiparametric autoantibody analysis may improve the early diagnosis of connective tissue diseases, particularly lupus and Sjögren’s syndrome, according to data published in Arthritis Research & Therapy.
Dazodalibep improves disease activity, symptoms in two Sjögren’s syndrome populations
Dazodalibep has successfully improved disease activity and symptoms two patient populations with Sjögren’s syndrome in a phase 2 trial, according to a press release from Horizon Therapeutics.
Making Sense of Sensory Ganglionopathies, Part 2
In this episode, Dr. Benjamin Claytor walks us through his approach to suspected sensory ganglionopathies. I also cover other neurologic complications of Sjogren’s syndrome and some interesting history on vitamin B6.
Making Sense of Sensory Ganglionopathies and Sjogren’s Syndrome
A sensational (or lack thereof) series on the signs and symptoms of the spellbinding sensory ganglionopathies.
Remibrutinib demonstrates ‘apparent efficacy’ in Sjogren’s syndrome
PHILADELPHIA — Results of a phase 2 proof-of-concept study showed that an oral Bruton’s tyrosine kinase inhibitor demonstrates trends toward efficacy in Sjögren's syndrome, according to data presented at ACR Convergence 2022.
ILD Day: Recent updates in treatment, management of interstitial lung disease
Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.
Patients with autoimmune disease receiving ICI exhibit better survival vs. controls
Although they exhibit a greater risk for severe immune-related adverse effects, patients with preexisting autoimmune disease receiving immune checkpoint inhibitors for melanoma had better 2-year survival than controls, according to data.
Risk for systemic autoimmune rheumatic diseases higher in areas with air pollution
Exposure to fine particulate matter — specifically particles 2.5 µm or less in diameter, or PM2.5 — in the air signals a higher risk for systemic autoimmune rheumatic diseases, according to data published in Arthritis Research & Therapy.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read